Humanized Patient-derived xenograft models for developing personalized therapy against Small Cell Lung Cancer
H. Rouhrazi (Izmir, Turkey), S. Erdem (Izmir, Turkey), V. Zafari (Izmir, Turkey), G. Esmailnia (Izmir, Turkey), R. Meuwissen (Izmir, Turkey)
Source: International Congress 2022 – Advanced models for drug discovery and functional changes in lung disease
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Rouhrazi (Izmir, Turkey), S. Erdem (Izmir, Turkey), V. Zafari (Izmir, Turkey), G. Esmailnia (Izmir, Turkey), R. Meuwissen (Izmir, Turkey). Humanized Patient-derived xenograft models for developing personalized therapy against Small Cell Lung Cancer. 2055
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|